An investigation for investors in Depomed Inc (NASDAQ:DEPO) shares over potential securities laws violations by Depomed was announced and NASDAQ:DEPO stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/16/2017 -- An investigation was announced on behalf of investors in NASDAQ:DEPO shares concerning possible violations of securities laws by Depomed in connection with certain financial statements.
Investors who purchased shares of Depomed Inc (NASDAQ:DEPO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by Depomed Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On August 7, 2017, during aftermarket hours, Depomed Inc announced that it had received a request for information relating to the promotion of opioids from the U.S. Senate Committee on Homeland Security and Governmental Affairs, as well as from the Office of the Attorney General of Maryland and the U.S. Department of Justice. Shares of Depomed Inc (NASDAQ:DEPO) declined from $25.20 per share in October 2016 to as low as $5.88 per share on August 15, 2017.
Those who purchased shares of Depomed Inc (NASDAQ:DEPO) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com